4 Canadian Marijuana Stocks Set for Big Revenue Growth?

The Canadian marijuana stocks on our list have been granted a sales license by Health Canada recently

SmallCapPower | August 23, 2018: Today we have identified four Canadian marijuana stocks that have acquired their license to sell cannabis within the past five months. Although there are more than 100 cannabis-related companies in Canada, there are significantly fewer companies with a license to sell, which gives companies like those we have weeded out today a distinct advantage when recreational use of marijuana is legalized in Canada on October 17, 2018.

For Our Complete Coverage Of Canadian Marijuana Stocks Click Here    

Watch: Cannex Capital Holdings (CSE:CNNX) Wants to Emerge as a Multi-State U.S. Player, Says CEO 

48North Cannabis Corp. (TSXV:NRTH) – $0.62
Cannabis

48North Cannabis is a Canada-based company focused on the production and distribution of cannabis-infused products. The Company develops CBD/THC infused products specifically designed to target the women’s health and wellness market. Product offerings include: food, beverage, cosmetics and skincare products. On June 25, 2018, 48North’s 100% owned cultivation facility received its cannabis sales license from Health Canada. Currently, 48North produces at a rate of 2,500 kg/year from its 40,000 sq. ft. indoor facility. In the future, the Company predicts annual production of 42,500 kg/year following the development of a 200,000 sq. ft. greenhouse.

  • Market Cap: $52.3 Million
  • 1 Month Total Return: -13.9%
  • YTD Total Return: 47.6%

Auxly Cannabis Group Inc. (TSXV:XLY) – $0.88
Cannabis

Auxly Cannabis Group is a vertically-integrated cannabis company that invests and supports companies involved in cannabis cultivation. Auxly has formed partnerships with 15 cannabis producers in Canada as plans to quickly ramp up production to 19,000 kg per quarter by Q4/2019. Auxly gained its AMCPR selling license on July 23, 2018 through its subsidiary, Kolab Project Incorporated.

  • Market Cap: $438.2 Million
  • 1 Month Total Return: 1.1%
  • YTD Total Return: -48.5%

Emerald Health Therapeutics Inc. (TSXV:EMH) – $4.30
Cannabis

Emerald Health Therapeutics is a Canada-based company engaged in the medical marijuana industry. The Company operates an indoor cultivation facility in Victoria, British Columbia and intends to expand into additional greenhouses. Emerald estimates its 2020 capacity to be as much as 71,000 kg/year. The Company also offers analytical testing of cannabis through an interest in Northern Vine Canada Inc. Emerald gained its AMCPR selling license on July 30, 2018.

  • Market Cap: $587.7 Million
  • 1 Month Total Return: 43.6%
  • YTD Total Return: -28.6%

Vivo Cannabis Inc. (TSXV:VIVO) – $1.35
Cannabis

Formerly known as ABcann Global Corporation (TSXV:ABCN), Vivo Cannabis manufactures and distributes medical cannabis. The Company gained its production and sales license from Health Canada in April 2018. Vivo’s capacity estimates for 2019 include 1,500 kg of cannabis grown indoor with 14,000 kg being grown in greenhouse facilities. On August 21, 2018, Vivo announced that it had completed an agreement to supply the Ontario Cannabis Store (the sole legal online retailer for recreational cannabis in Ontario) with 16 cannabis products following the legalization date in October.

  • Market Cap: $243.1 Million
  • 1 Month Total Return: 18.4%
  • YTD Total Return: -11.8%

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: